| Treatment Patterns and Persistence With GLP-1 RA Treatments Among Patients With Type 2 Diabetes in France: A Retrospective Cohort Analysis | Diabetes Therapy | 4 days | save |  |  |  |  |
| Glucagon-Like Peptide 1 Receptor Agonists in Type 2 Diabetes Mellitus: Data from a Real-World Study in Spain | Diabetes Therapy | 5 days | save | | | | |
| The Cost-Effectiveness of Empagliflozin Versus Liraglutide Treatment in People with Type 2 Diabetes and Established Cardiovascular Disease | Diabetes Therapy | 7 days | save | | | | |
| Effect of Group Patient Education on Glycemic Control Among People Living with Type 2 Diabetes in Vietnam: A Randomized Controlled Single-Center Trial | Diabetes Therapy | 11 days | save | | | | |
| Glycemic Control and Prevention of Diabetic Complications in Low- and Middle-Income Countries: An Expert Opinion | Diabetes Therapy | 11 days | save | | | | |
| Time to Failure on Oral Glucose-Lowering Agents for Patients with Type 2 Diabetes: A Retrospective Cohort Study | Diabetes Therapy | 12 days | save | | | | |
| Diabetes and Frailty: An Expert Consensus Statement on the Management of Older Adults with Type 2 Diabetes | Diabetes Therapy | 13 days | save | | | | |
| Are Chinese Patients with Type 2 Diabetes and a Body Mass Index of 27.5–32.5 kg/m 2 Suitable for Metabolic Surgery? A One-Year Post-Surgery Study | Diabetes Therapy | 34 days | save | | | | |
| Effects of Sodium Glucose Co-Transporter 2 Inhibitors in Type 1 Diabetes Mellitus on Body Composition and Glucose Variabilities: Single-Arm, Exploratory Trial | Diabetes Therapy | 34 days | save | | | | |
| Role of Structured Education in Reducing Lypodistrophy and its Metabolic Complications in Insulin-Treated People with Type 2 Diabetes: A Randomized Multicenter Case–Control Study | Diabetes Therapy | 34 days | save | | | | |
| Glycemic Variability and Time in Range During Self-titration of Once Daily Insulin Glargine 300 U/ml Versus Neutral Protamine Hagedorn Insulin in Insulin-naïve Chinese Type 2 Diabetes Patients | Diabetes Therapy | 34 days | save | | | | |
| Diabetic Ketoacidosis at Emergency Department Presentation During the First Months of the SARS-CoV-2 Pandemic in Israel: A Multicenter Cross-Sectional Study | Diabetes Therapy | 36 days | save | | | | |
| Once-Daily Oral Semaglutide Versus Injectable GLP-1 RAs in People with Type 2 Diabetes Inadequately Controlled on Basal Insulin: Systematic Review and Network Meta-analysis | Diabetes Therapy | 37 days | save | | | | |
| Efficacy and Safety of Ertugliflozin in Patients with Type 2 Diabetes Inadequately Controlled by Metformin and Sulfonylurea: A Sub-Study of VERTIS CV | Diabetes Therapy | 37 days | save | | | | |
| All-Cause and Cardiovascular Mortality Among Insulin-Naïve People With Type 2 Diabetes Treated With Insulin Detemir or Glargine: A Cohort Study in the UK | Diabetes Therapy | 38 days | save | | | | |
| Expert Opinion: A Call for Basal Insulin Titration in Patients with Type 2 Diabetes in Daily Practice: Southeast European Perspective | Diabetes Therapy | 38 days | save | | | | |
| Reduction of Depression in Diabetes: A New Pleiotropic Action of Metformin? | Diabetes Therapy | 39 days | save | | | | |
| Guideline Adherence and Associated Outcomes in the Treatment of Type 2 Diabetes Mellitus Patients With an Incident Cardiovascular Comorbidity: An Analysis Based on a Large German Claims Dataset | Diabetes Therapy | 40 days | save | | | | |
| Prevalence of Cardiovascular and Renal Co-morbidities in Patients with Type 2 Diabetes in the Gulf, a Cross-sectional Observational Study | Diabetes Therapy | 42 days | save | | | | |
| Efficacy and Safety of Ertugliflozin in Patients With Diabetes Mellitus Inadequately Controlled by Sulfonylurea Monotherapy: a Substudy of VERTIS CV | Diabetes Therapy | 42 days | save | | | | |
| Bruising: A Neglected, Though Patient-Relevant Complication of Insulin Injections Coming to Light from a Real-Life Nationwide Survey | Diabetes Therapy | 43 days | save | | | | |
| A Claims Database Analysis of Dose-Dependency of Metformin and Incidence of Lactic Acidosis in Japanese Patients with Type 2 Diabetes | Diabetes Therapy | 45 days | save | | | | |
| Oral Semaglutide Reduces HbA 1c and Body Weight in Patients with Type 2 Diabetes Regardless of Background Glucose-Lowering Medication: PIONEER Subgroup Analyses | Diabetes Therapy | 45 days | save | | | | |
| Fasting Blood Glucose and 2-h Postprandial Blood Glucose Predict Hypertension: A Report from the REACTION Study | Diabetes Therapy | 45 days | save | | | | |
| Sodium–Glucose Co-Transporter 2 Inhibitors (SGLT2i) Exposure and Outcomes in Type 2 Diabetes: A Systematic Review of Population-Based Observational Studies | Diabetes Therapy | 45 days | save | | | | |
| Impact of Age on the Effectiveness and Safety of Insulin Glargine 300 U/mL: Results from the REALI European Pooled Data Analysis | Diabetes Therapy | 49 days | save | | | | |
| The Effects of Dietary Nutrition Intake on Glycemic Variability in Type 1 Diabetes Mellitus Adults | Diabetes Therapy | 49 days | save | | | | |
| Ten-Year Outcomes of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Patients with Type 2 Diabetes Mellitus Suffering from Left Main Coronary Disease: A Meta-Analysis | Diabetes Therapy | 49 days | save | | | | |
| Glucagon-Like Peptide 1 Receptor Agonist (GLP1RA) Exposure and Outcomes in Type 2 Diabetes: A Systematic Review of Population-Based Observational Studies | Diabetes Therapy | 49 days | save | | | | |
| Effect of Sitagliptin on Serum Irisin Levels in Patients with Newly Diagnosed Type 2 Diabetes Mellitus | Diabetes Therapy | 49 days | save | | | | |
| Switch-to-Semaglutide Study (STS-Study): a Retrospective Cohort Study | Diabetes Therapy | 57 days | save | | | | |
| A Pragmatic Study of Basal and Mid-Mixture Insulins as Starter Insulins in Chinese Patients With Type 2 Diabetes: Observations From Long-Term, Real-World Experience | Diabetes Therapy | 57 days | save | | | | |
| What is Diabetes Remission? | Diabetes Therapy | 60 days | save | | | | |
| Real-World Effectiveness and Safety of Insulin Glargine 300 U/mL in Patients with T2D Uncontrolled on NPH or Premixed Insulins as Part of Routine Clinical Practice in Bulgaria: ToUPGRADE Study | Diabetes Therapy | 62 days | save | | | | |
| Effects of Increasing Metformin Dose vs Adding/Switching to Dipeptidyl Peptidase-4 Inhibitors on Glycemic Control in Patients with Type 2 Diabetes | Diabetes Therapy | 63 days | save | | | | |
| Outcomes in GLP-1 RA-Experienced Patients Switching to Once-Weekly Semaglutide in a Real-World Setting: The Retrospective, Observational EXPERT Study | Diabetes Therapy | 64 days | save | | | | |
| Efficacy and Safety of Luseogliflozin in Patients with Type 2 Diabetes Complicated by Hepatic Dysfunction: A Single-Site, Single-Arm, Open-Label, Exploratory Trial | Diabetes Therapy | 64 days | save | | | | |
| Empagliflozin Improves Liver Steatosis and Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial | Diabetes Therapy | 66 days | save | | | | |
| Glucose Variability is Independently Correlated with Serum Level of Pigment Epithelium-Derived Factor in Type 2 Diabetes | Diabetes Therapy | 66 days | save | | | | |
| Injection Technique Education in Patients with Diabetes Injecting Insulin into Areas of Lipohypertrophy: A Randomized Controlled Trial | Diabetes Therapy | 69 days | save | | | | |
| Real-World Clinical Experience of Semaglutide in Secondary Care Diabetes: A Retrospective Observational Study | Diabetes Therapy | 71 days | save | | | | |
| Delphi-Based Consensus on Treatment Intensification in Type 2 Diabetes Subjects Failing Basal Insulin Supported Oral Treatment: Focus on Basal Insulin + GLP-1 Receptor Agonist Combination Therapies | Diabetes Therapy | 73 days | save | | | | |
| Impact of Intensive Glucose Control on Brain Health: Meta-Analysis of Cumulative Data from 16,584 Patients with Type 2 Diabetes Mellitus | Diabetes Therapy | 74 days | save | | | | |
| Effectiveness and Safety of Switching Rapid-Acting Insulins to Insulin Glulisine in Patients with Diabetes: The Observational IGLU-S Study | Diabetes Therapy | 75 days | save | | | | |
| Effectiveness and Safety of Insulin Glulisine When Initiating Supplementary Prandial Insulin Treatment (SIT) in Insulin-Naïve Patients with Type 2 Diabetes: The Observational IGLU-SIT Study | Diabetes Therapy | 75 days | save | | | | |
| The Position of Gliclazide in the Evolving Landscapes and Disease Continuum of T2DM: A Collaborative Delphi Survey-Based Consensus from India | Diabetes Therapy | 83 days | save | | | | |
| What’s in a Name? Redefining Type 2 Diabetes Remission | Diabetes Therapy | 87 days | save | | | | |
| Effects of Switching from Liraglutide or Dulaglutide to Subcutaneous Semaglutide on Glucose Metabolism and Treatment Satisfaction in Patients with Type 2 Diabetes: Protocol for a Multicenter, Prospective, Randomized, Open-Label, Blinded-Endpoint, Par | Diabetes Therapy | 87 days | save | | | | |
| Skin Autofluorescence in Young Adult Offspring of Women with Type 1 Diabetes: A Cross-Sectional Case–Control Study | Diabetes Therapy | 88 days | save | | | | |
| Baseline HbA1c Level Influences the Effect of Periodontal Therapy on Glycemic Control in People with Type 2 Diabetes and Periodontitis: A Systematic Review on Randomized Controlled Trails | Diabetes Therapy | 89 days | save | | | | |
| | 
report | next » |
| |
